Sernova Biotherapeutics Inc Stock
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1050 CAD | -16.00% |
|
-22.22% | -19.23% |
| Market Cap | 39.65M 28.21M 24.65M 22.79M 21.06M 2.71B 40.37M 272M 107M 1.33B 106M 104M 4.57B | P/E 2026 * |
-3.5x | P/E 2027 * | -2.63x |
|---|---|---|---|---|---|
| Enterprise Value | 39.65M 28.21M 24.65M 22.79M 21.06M 2.71B 40.37M 272M 107M 1.33B 106M 104M 4.57B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 7.93x |
| Free-Float |
86.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -16.00% | ||
| 1 week | -22.22% | ||
| Current month | -22.22% | ||
| 1 month | -27.59% | ||
| 3 months | -43.24% | ||
| 6 months | -27.59% | ||
| Current year | -19.23% |
| 1 week | 0.1 |  | 0.13 |
| 1 month | 0.1 | | 0.17 |
| Current year | 0.1 | | 0.2 |
| 1 year | 0.1 | | 0.21 |
| 3 years | 0.1 | | 0.99 |
| 5 years | 0.1 | | 2.22 |
| 10 years | 0.1 | | 2.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Rigby
CEO | Chief Executive Officer | 58 | 12/08/2024 |
James Parsons
DFI | Director of Finance/CFO | 60 | 11/10/2024 |
David Burke
IRC | Investor Relations Contact | - | 11/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Tanya Lewis
BRD | Director/Board Member | 55 | - |
John Brooks
CHM | Chairman | 75 | 23/09/2025 |
James Parsons
BRD | Director/Board Member | 60 | 19/04/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-22 | Option | Director | 260,000 | 0.0748% | ||
| 05-22 | Option | Director | 194,229 | 0.0559% | ||
| 05-22 | Option | Chairman | 360,000 | 0.1035% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -16.00% | -22.22% | -36.36% | -89.39% | 28.05M | |
| -5.26% | -4.67% | -19.70% | +3.93% | 127B | |
| -3.51% | -2.41% | -0.45% | -5.59% | 13.02B | |
| -0.36% | +1.76% | +47.14% | +93.83% | 8.97B | |
| -0.52% | -5.59% | -50.34% | -73.65% | 3.86B | |
| +2.97% | +1.34% | +26.02% | +48.78% | 2.74B | |
| +0.47% | -11.78% | -18.69% | -28.77% | 1.66B | |
| +3.48% | -0.70% | -3.98% | -22.19% | 1.59B | |
| -4.55% | -1.61% | -21.43% | -61.51% | 1.51B | |
| Average | -2.60% | -0.81% | -8.65% | -14.95% | 17.83B | |
| Weighted average by Cap. | -4.53% | +2.03% | -14.22% | +5.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 5M 3.56M 3.11M 2.87M 2.66M 342M 5.09M 34.27M 13.45M 167M 13.36M 13.07M 576M |
| Net income | -12.83M -9.13M -7.98M -7.37M -6.81M -877M -13.06M -87.92M -34.5M -429M -34.28M -33.52M -1.48B | -19.77M -14.07M -12.29M -11.36M -10.5M -1.35B -20.13M -136M -53.17M -662M -52.84M -51.67M -2.28B |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/07/26 | CA$0.1050 | -16.00% | 346,853 |
| 10/07/26 | CA$0.1250 | -3.85% | 155,027 |
| 09/07/26 | CA$0.1300 | 0.00% | 110,276 |
| 08/07/26 | CA$0.1300 | 0.00% | 15,100 |
| 07/07/26 | CA$0.1300 | -3.70% | 62,135 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1050CAD
Average target price
0.4500CAD
Spread / Average Target
+328.57%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SVA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
